Targeted Deep Sequencing Reveals Unrecognized KIT Mutation Coexistent with NF1 Deficiency in GISTs

References

• von Mehren M, Joensuu H. Gastrointestinal stromal tumors. J clin oncol. 2018;36(2):136–143. doi:10.1200/JCO.2017.74.970529220298
   PubMed Web of Science ®Google Scholar
• Philpott C, Tovell H, Frayling IM, Cooper DN, Upadhyaya M. The NF1 somatic mutational landscape in sporadic human cancers. Hum Genomics. 2017;11(1):13. doi:10.1186/s40246-017-0109-328637487
   PubMed Web of Science ®Google Scholar
• Giuly JA, Picand R, Giuly D, Monges B. Von Recklinghausen disease and gastrointestinal stromal tumors. Am J Surg. 2003;185(1):86–87. doi:10.1016/S0002-9610(02)01111-X12531453
   PubMed Web of Science ®Google Scholar
• Uusitalo E, Rantanen M, Kallionpää RA, et al. Distinctive cancer associations in patients with neurofibromatosis type 1. J clin oncol. 2016;34(17):1978–1986. doi:10.1200/JCO.2015.65.357626926675
   PubMed Web of Science ®Google Scholar
• Gasparotto D, Rossi S, Polano M, et al. Quadruple-negative gist is a sentinel for unrecognized neurofibromatosis type 1 syndrome. Clin Cancer Res. 2017;23(1):273–282. doi:10.1158/1078-0432.CCR-16-015227390349
   PubMed Web of Science ®Google Scholar
• Belinsky MG, Rink L, Cai KQ, et al. Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case. BMC Cancer. 2015;15:887. doi:10.1186/s12885-015-1872-y26555092
   PubMed Web of Science ®Google Scholar
• Burgoyne AM, De Siena M, Alkhuziem M, et al. Duodenal-jejunal flexure gi stromal tumor frequently heralds somatic nf1 and notch pathway mutations. JCO Precision Oncol. 2017;2017:2017. doi:10.1200/PO.17.00014
   Google Scholar
• Li K, Tjhoi W, Shou C, et al. Multiple gastrointestinal stromal tumors: analysis of clinicopathologic characteristics and prognosis of 20 patients. Cancer Manag Res. 2019;11:7031–7038. doi:10.2147/CMAR.S19756031413638
   PubMed Web of Science ®Google Scholar
• Astolfi A, Indio V, Nannini M, et al. Targeted deep sequencing uncovers cryptic kit mutations in KIT/PDGFRA/SDH/RAS-P wild-type GIST. Front Oncol. 2020;10:504. doi:10.3389/fonc.2020.0050432391261
   PubMed Web of Science ®Google Scholar
• Salvi PF, Lorenzon L, Caterino S, Antolino L, Antonelli MS, Balducci G. Gastrointestinal stromal tumors associated with neurofibromatosis 1: a single centre experience and systematic review of the literature including 252 cases. Int J Surg Oncol. 2013;2013:398570. doi:10.1155/2013/39857024386562
   PubMedGoogle Scholar
• Mussi C, Schildhaus HU, Gronchi A, Wardelmann E, Hohenberger P. Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1. Clin Cancer Res. 2008;14(14):4550–4555. doi:10.1158/1078-0432.CCR-08-008618628470
   PubMed Web of Science ®Google Scholar
• Namgung H. Gastrointestinal stromal tumor with KIT mutation in neurofibromatosis type 1. J Korean Surg Soc. 2011;81(4):276–280. doi:10.4174/jkss.2011.81.4.27622111084
   PubMedGoogle Scholar
• Cheng SP, Huang MJ, Yang TL, et al. Neurofibromatosis with gastrointestinal stromal tumors: insights into the association. Dig Dis Sci. 2004;49(7–8):1165–1169. doi:10.1023/B:DDAS.0000037806.14471.a215387340
   PubMed Web of Science ®Google Scholar
• Takazawa Y, Sakurai S, Sakuma Y, et al. Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen’s disease). Am J Surg Pathol. 2005;29(6):755–763. doi:10.1097/01.pas.0000163359.32734.f915897742
   PubMed Web of Science ®Google Scholar
• Tokunaga M, Nanjo S, Yoshita H, et al. Multiple synchronous sporadic gastrointestinal stromal tumors in the stomach and jejunum. Internal Medicine. 2018;57(12):1719–1723. doi:10.2169/internalmedicine.0229-1729434135
   PubMed Web of Science ®Google Scholar
• Yantiss RK, Rosenberg AE, Sarran L, Besmer P, Antonescu CR. Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study. Modern Pathol. 2005;18(4):475–484. doi:10.1038/modpathol.3800334
   PubMed Web of Science ®Google Scholar
• Mei L, Smith SC, Faber AC, et al. Gastrointestinal stromal tumors: the gist of precision medicine. Trends in Cancer. 2018;4(1):74–91. doi:10.1016/j.trecan.2017.11.00629413424
   PubMed Web of Science ®Google Scholar
• Kinoshita K, Hirota S, Isozaki K, et al. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol. 2004;202(1):80–85. doi:10.1002/path.148714694524
   PubMed Web of Science ®Google Scholar
• Miettinen M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol. 2006;30(1):90–96. doi:10.1097/01.pas.0000176433.81079.bd16330947
   PubMed Web of Science ®Google Scholar
• Gao J, Li J, Li Y, et al. Intratumoral KIT mutational heterogeneity and recurrent KIT/PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumors. Oncotarget. 2016;7(21):30241–30249. doi:10.18632/oncotarget.714826848617
   PubMedGoogle Scholar
• Szucs Z, Thway K, Fisher C, et al. Molecular subtypes of gastrointestinal stromal tumors and their prognostic and therapeutic implications. Future Oncol. 2017;13(1):93–107. doi:10.2217/fon-2016-019227600498
   PubMed Web of Science ®Google Scholar
• Miettinen M, Lasota J, Sobin LH. Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am J Surg Pathol. 2005;29(10):1373–1381. doi:10.1097/01.pas.0000172190.79552.8b16160481
   PubMed Web of Science ®Google Scholar
• Badache A, Muja N, De Vries GHD. Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis. Oncogene. 1998;17(6):795–800. doi:10.1038/sj.onc.12019789715282
   PubMed Web of Science ®Google Scholar
• Ryan JJ, Klein KA, Neuberger TJ, et al. Role for the stem cell factor/KIT complex in Schwann cell neoplasia and mast cell proliferation associated with neurofibromatosis. J Neurosci Res. 1994;37(3):415–432. doi:10.1002/jnr.4903703147513766
   PubMed Web of Science ®Google Scholar
• Bajor J. Gastrointestinal stromal tumors in neurofibromatosis type 1. Orv Hetil. 2009;150(4):149–153. doi:10.1556/oh.2009.2847819144598
   PubMedGoogle Scholar
• Shinomura Y, Kinoshita K, Tsutsui S, Hirota S. Pathophysiology, diagnosis, and treatment of gastrointestinal stromal tumors. J Gastroenterol. 2005;40(8):775–780. doi:10.1007/s00535-005-1674-016143881
   PubMed Web of Science ®Google Scholar
• Kalender M, Sevinc A, Tutar E, Sirikci A, Camci C. Effect of sunitinib on metastatic gastrointestinal stromal tumor in patients with neurofibromatosis type 1: a case report. World j Gastroenterol. 2007;13(18):2629–2632. doi:10.3748/wjg.v13.i18.262917552016
   PubMed Web of Science ®Google Scholar
• Fujimi A, Nagamachi Y, Yamauchi N, et al. Gastrointestinal stromal tumor in a patient with neurofibromatosis type 1 that was successfully treated with regorafenib. Internal Medicine. 2019;58(13):1865–1870. doi:10.2169/internalmedicine.2321-1830918185
   PubMed Web of Science ®Google Scholar
• Nishida T, Tsujimoto M, Takahashi T, Hirota S, Blay JY, Wataya-Kaneda M. Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I. J Gastroenterol. 2016;51(6):571–578. doi:10.1007/s00535-015-1132-626511941
   PubMed Web of Science ®Google Scholar